Thyroid hormones and minerals in immunocorrection of disorders in autoimmune thyroid diseases

被引:12
作者
Kravchenko, Viktor [1 ]
Zakharchenko, Tamara [1 ]
机构
[1] Vasily Pavlovich Komisarenko Inst Endocrinol & Met, Epidemiol Endocrine Dis, Kiev, Ukraine
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
autoimmune thyroid diseases; thyroid hormones; iodine; selenium; zinc; iron; magnesium; immunomodulating effect; GRAVES-DISEASE; HASHIMOTO-THYROIDITIS; SELENIUM SUPPLEMENTATION; OXIDATIVE STRESS; IMMUNE-SYSTEM; MAGNESIUM-DEFICIENCY; SERUM SELENIUM; IODINE EXCESS; FREE-RADICALS; DOUBLE-BLIND;
D O I
10.3389/fendo.2023.1225494
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid hormones and essential elements iodine (I), selenium (Se), iron (Fe), copper (Cu), zinc (Zn), calcium (Ca), magnesium (Mg), etc. play an important role in the work of many organs and systems of the body, including the immune system and the thyroid gland, and a violation of their supply can be the cause of pathological changes in them. In pathology, the interaction between thyroid hormones (TG), minerals and the immune system is disturbed. The review of the literature examines the immunomodulatory role of TG, minerals, their properties, and their participation in the pathogenesis of autoimmune thyroid diseases (AITD). The study of the relationship between the excess or deficiency of minerals and AITD is described. The basis of the development of AITD - Hashimoto's thyroiditis (HT), Graves' disease (GD), Graves' ophthalmopathy (GO) is the loss of immune tolerance to thyroid antigens - thyroid peroxidase (TPO), thyroglobulin (Tg) and thyroid-stimulating hormone receptor (TSH-R). Immune-mediated mechanisms - production of autoantibodies to thyroid antigens and lymphocytic thyroid infiltration - are involved in the pathogenesis of AITD. Insufficiency of regulatory T cells (Treg) and regulatory B cells (Breg), imbalance between Th17-lymphocytes and Treg-lymphocytes, abnormal production of pro-inflammatory cytokines has a significant influence on the progression of AITD. With AITD, the balance between oxidants and antioxidants is disturbed and oxidative stress (OS) occurs. The lack of modern effective pharmacological therapy of AITD prompted us to consider the mechanisms of influence, possibilities of immunocorrection of pathogenetic factors using TG, micro/macronutrients. In order to develop a more effective treatment strategy, as well as approaches to prevention, a critical analysis of the ways of immunotherapeutic use of dietary supplements of I, Se, Zn, Mg and other minerals in AITD was carried out.
引用
收藏
页数:13
相关论文
共 144 条
  • [1] Cell iron status influences macrophage polarization
    Agoro, Rafiou
    Taleb, Meriem
    Quesniaux, Valerie F. J.
    Mura, Catherine
    [J]. PLOS ONE, 2018, 13 (05):
  • [2] Anaya J., 2013, CLIN REV ALLERG IMMU
  • [3] Graves' disease: Epidemiology, genetic and environmental risk factors and viruses
    Antonelli, Alessandro
    Ferrari, Silvia Martina
    Ragusa, Francesca
    Elia, Giusy
    Paparo, Sabrina Rosaria
    Ruffilli, Ilaria
    Patrizio, Armando
    Giusti, Claudia
    Gonnella, Debora
    Cristaudo, Alfonso
    Foddis, Rudy
    Shoenfeld, Yehuda
    Fallahi, Poupak
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 34 (01)
  • [4] Autoimmune thyroid disorders
    Antonelli, Alessandro
    Ferrari, Silvia Martina
    Corrado, Alda
    Di Domenicantonio, Andrea
    Fallahi, Poupak
    [J]. AUTOIMMUNITY REVIEWS, 2015, 14 (02) : 174 - 180
  • [5] Attard Carol Cardona, 2022, Proc (Bayl Univ Med Cent), V35, P608, DOI 10.1080/08998280.2022.2087038
  • [6] Iodine and Myo-Inositol: A Novel Promising Combination for Iodine Deficiency
    Barbaro, Daniele
    Orru, Beatrice
    Unfer, Vittorio
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [7] Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management
    Barrio-Barrio, Jesus
    Sabater, Alfonso L.
    Bonet-Farriol, Elvira
    Velazquez-Villoria, Alvaro
    Galofre, Juan C.
    [J]. JOURNAL OF OPHTHALMOLOGY, 2015, 2015
  • [8] The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy
    Bartalena, L.
    Kahaly, G. J.
    Baldeschi, L.
    Dayan, C. M.
    Eckstein, A.
    Marcocci, C.
    Marino, M.
    Vaidya, B.
    Wiersinga, W. M.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 185 (04) : G43 - G67
  • [9] Challenges and perspectives of selenium supplementation in Graves' disease and orbitopathy
    Bednarczuk, Tomasz
    Schomburg, Lutz
    [J]. HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 19 (01): : 31 - 39
  • [10] The differences in T and B cell subsets in thyroid of children with Graves' disease and Hashimoto's thyroiditis
    Ben-Skowronek, Iwona
    Szewczyk, Leszek
    Kulik-Rechberger, Beata
    Korobowicz, Elzbieta
    [J]. WORLD JOURNAL OF PEDIATRICS, 2013, 9 (03) : 245 - 250